FAP and neoplasm: In early-stage lung adenocarcinoma (stage IA), 18F-FAPI-04 PET/CT demonstrated higher SUVmax and tumor-to-background ratios than FDG, with tracer uptake correlating with FAP expression on immunohistochemistry [171].